Tactile Systems Technology (TCMD) Gains from Sales and Divestitures (2016 - 2026)
Tactile Systems Technology (TCMD) reported Gains from Sales and Divestitures of $95377.0 for Q1 2026, down 59.15% year-over-year from $233509.0 in Q1 2025, and down 76.51% quarter-over-quarter from $406102.0 in Q4 2025.
Tactile Systems Technology (TCMD) Gains from Sales and Divestitures (2016 - 2026) Analysis & Trends
Tactile Systems Technology (TCMD) has 11 years of Gains from Sales and Divestitures data on file, last reported at $95377.0 in Q1 2026.
- Gains from Sales and Divestitures for Q1 2026 came in at $95377.0, down 59.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $95377.0 (down 59.15% YoY), and the FY2025 annual result was $406102.0, up 819.57% from the prior year.
- Gains from Sales and Divestitures fell to $95377.0 in Q1 2026 per TCMD's latest filing, from $406102.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $406102.0 in Q4 2025 and troughed at $1853.0 in Q1 2022.
- A 5-year average of $132802.9 and a median of $95377.0 in 2026 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2022 and 2023: Gains from Sales and Divestitures sank 98.04% in 2022, then soared 12651.43% in 2023.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $4407.0 in 2022, then surged by 6041.39% to $270651.0 in 2023, then tumbled by 83.68% to $44162.0 in 2024, then soared by 819.57% to $406102.0 in 2025, then plunged by 76.51% to $95377.0 in 2026.
- Business Quant data shows TCMD's Gains from Sales and Divestitures at $95377.0 in Q1 2026, $406102.0 in Q4 2025, and $389357.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Tactile Systems Technology | 589.75 Mn | 499.55 Mn | 57.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 95,377.00 |
| Mar 31, 2026 | 95,377.00 |
| Dec 31, 2025 | 406,102.00 |
| Dec 31, 2025 | 406,102.00 |
| Sep 30, 2025 | 389,357.00 |
| Sep 30, 2025 | 389,357.00 |
| Jun 30, 2025 | 120,436.00 |
| Jun 30, 2025 | 120,436.00 |
| Mar 31, 2025 | 233,509.00 |
| Mar 31, 2025 | 233,509.00 |
| Dec 31, 2024 | 44,162.00 |
| Dec 31, 2024 | 44,162.00 |
| Sep 30, 2024 | 254,490.00 |
| Sep 30, 2024 | 254,490.00 |
| Jun 30, 2024 | 44,162.00 |
| Jun 30, 2024 | 44,162.00 |
| Mar 31, 2024 | 133,324.00 |
| Mar 31, 2024 | 133,324.00 |
| Dec 31, 2023 | 270,651.00 |
| Dec 31, 2023 | 270,651.00 |